Analysis

To counter their record revenues, many insurers are offering cost-sharing waivers for COVID-19 treatments, with a few are also offering additional measures like premium relief.

The U.S. has made little progress toward meaningful implementation of population health.

Third-party and in-house portfolio management both have pros and cons, the data provider says.

October Three study finds these sponsors in particular could have reduced costs by accelerating funding, reducing headcounts and more.

Observers are puzzled by the timing of the move.

A recent study from UnitedHealth offers a glimpse of how payment reform can improve key patient outcomes.

But it's not what you think: spending for mental health and substance use makes up a small fraction of total health care spending.

The benefits challenges employers face may not be changing much, but COVID-19 will affect how employers tackle them.